KEQU insider sale: 3,000 shares; CFO retains 11,564 shares
Rhea-AI Filing Summary
Donald T. Gardner III, Chief Financial Officer and director, reported a sale of 3,000 shares of Kewaunee Scientific Corp (KEQU) on 10/09/2025 at a weighted average price of $42.76 per share. After the transactions, he beneficially owned 11,564 shares. The filing states the sale occurred in multiple trades priced between $42.68 and $43.57, and the reporting person offered to provide a breakdown of shares sold at each price upon request. The Form 4 is signed and dated 10/10/2025, indicating timely disclosure of the insider transaction.
Positive
- Timely disclosure of the insider sale via a signed Form 4 dated 10/10/2025
- Transparency about trade price range ($42.68–$43.57) and offer to provide per-trade details
- Significant retained stake of 11,564 shares after the sale
Negative
- Reduction in insider holdings by 3,000 shares on 10/09/2025
- No statement in the filing that the sale was made under a 10b5-1 plan (no such box checked)
Insights
Insider disclosed a modest share sale and retains a meaningful position.
The CFO sold 3,000 shares at a weighted average price of $42.76, reducing his stake to 11,564 shares. This is a clear, documented change in beneficial ownership reported on a Form 4 and the filing offers further granularity on execution prices between $42.68 and $43.57.
The primary dependency is whether the sale was routine (e.g., diversification or liquidity) or part of a plan; the filing does not state a 10b5-1 plan. Investors may observe insider activity near 10/09/2025 as a near-term signal of personal trading but should not infer motive from the filing alone.
Filing shows compliance with Section 16 reporting requirements.
The Form 4 includes the required transaction date, quantities, weighted average price, and a signer’s certification dated 10/10/2025. The disclosure that sales occurred across prices and the offer to provide per-trade detail supports transparency in reporting execution details.
Key items to monitor are any further Form 4 filings from the same reporting person and whether future filings indicate a pattern of disposals or purchases over the following weeks to months.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,000 | $42.76 | $128K |
Footnotes (1)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.68 to $43.57 inclusive. The reporting person undertakes to provide Kewaunee Scientific Corporation ("Kewaunee"), any security holder of Kewaunee, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
AI-generated analysis. How Rhea-AI works. Not financial advice.
